Jeff Reese

From left, Jennifer Herington, PhD, Jeff Reese, MD, Elaine Shelton, PhD, and Shajila Siricilla, PhD, are studying whether drugs given to premature infants in the NICU contribute to patent ductus arteriosus.
August 18, 2022

Study seeks to explore drug link to fetal vessel defect

Vanderbilt researchers have received a grant to study whether drugs given to premature infants in the neonatal intensive care unit (NICU) contribute to a potentially lethal condition called patent ductus arteriosus.

By Bill Snyder
December 3, 2020

Six Vanderbilt faculty elected as 2020 fellows of the AAAS

Six Vanderbilt University faculty members have been elected 2020 fellows of the American Association for the Advancement of Science, an honor bestowed upon AAAS members by their peers.

By Marissa Shapiro
October 15, 2014

Antibiotics, fetal vessel defect linked

Certain antibiotics increase the risk of a congenital heart disorder called patency of the ductus arteriosis.

By VUMC News and Communications
Heart illustration
April 2, 2014

Development and disease in the aorta

Smooth muscle cells that line the aorta differ in development but not in the adult, a finding that has implications for understanding aortic development and disease.

By Peng Xu
June 12, 2013

Antacids: risky for premature babies

Antacids that block a certain enzyme pose a risk for a common cardiac problem in premature infants.

By Leigh MacMillan